Month 60 Imaging Findings and Relationship to Treatment Outcomes Following Anti-VEGF Therapy for Macular Edema Due to Central or Hemi-Retinal Vein Occlusion
Author:
Funder
National Eye Institute
Publisher
Elsevier BV
Subject
Ophthalmology
Reference43 articles.
1. Effect of bevacizumab vs aflibercept on visual acuity among patients with macular edema due to central retinal vein occlusion: the SCORE2 randomized clinical trial;Scott;JAMA,2017
2. Spectral domain OCT predictors of visual acuity in the Study of Comparative Treatments for Retinal Vein Occlusion 2: SCORE 2 Report 15;Etheridge;Ophthalmol Retina,2021
3. SCORE2 Report 17: macular thickness fluctuations in anti-VEGF-treated patients with central or hemiretinal vein occlusion;Etheridge;Graefes Arch Clin Exp Ophthalmol,2022
4. SCORE2 Report 13: intraretinal hemorrhage changes in eyes with central or hemiretinal vein occlusion managed with aflibercept, bevacizumab or observation. Secondary analysis of the SCORE and SCORE2 clinical trials;Hendrick;Am J Ophthalmol,2021
5. Association between early and late response in eyes with central or hemiretinal vein occlusion treated with anti-VEGF agents; SCORE2 report 12: secondary analysis of the SCORE2 clinical trial;Khurana;Graefes Arch Clin Exp Ophthalmol,2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3